应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DVA 达维塔保健
休市中 05-09 16:00:00 EDT
143.76
+0.13
+0.09%
盘后
143.76
+0.00
0.00%
19:43 EDT
最高
144.42
最低
142.76
成交量
66.45万
今开
143.59
昨收
143.63
日振幅
1.15%
总市值
110.50亿
流通市值
54.39亿
总股本
7,686万
成交额
9,542万
换手率
1.76%
流通股本
3,783万
市净率
91.23
ROE
51.74%
每股收益
10.73
52周最高
179.60
52周最低
131.44
市盈率
13.40
股息
0.00
股息收益率
0.00
ROA
7.15%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
巴菲特,又有大动作!
央视财经 · 02-21
巴菲特,又有大动作!
巴菲特大动作!
中国基金报 · 02-21
巴菲特大动作!
德维特2024财年实现净利润9.36亿美元,同比增加35.26%
市场透视 · 02-17
德维特2024财年实现净利润9.36亿美元,同比增加35.26%
德维特盘中异动 急速跳水12.48%报154.97美元
市场透视 · 02-14
德维特盘中异动 急速跳水12.48%报154.97美元
业绩指引疲软、大股东巴菲特抛售 DaVita(DVA.US)盘前走低
智通财经 · 02-14
业绩指引疲软、大股东巴菲特抛售 DaVita(DVA.US)盘前走低
异动解读 | 达维塔保健2025年利润预期低于预期,股价盘后暴跌近10%
异动解读 · 02-13
异动解读 | 达维塔保健2025年利润预期低于预期,股价盘后暴跌近10%
DaVita(DVA.US):2024年Q4财报实现营收32.947亿美元,前值为31.46亿美元,预期值为32.66亿美元;每股收益为2.24美元,前值为1.87美元,预期值为2.14美元。
金融界 · 02-13
DaVita(DVA.US):2024年Q4财报实现营收32.947亿美元,前值为31.46亿美元,预期值为32.66亿美元;每股收益为2.24美元,前值为1.87美元,预期值为2.14美元。
DaVita第四季度调整后每股收益$2.24,超过预期的$2.14,销售额$32.9亿超过预期的$32.7亿
财报速递 · 02-13
DaVita第四季度调整后每股收益$2.24,超过预期的$2.14,销售额$32.9亿超过预期的$32.7亿
三只值得散户入手的巴菲特概念股,只要250美元就能追随“股神”
老虎资讯综合 · 2024-12-23
三只值得散户入手的巴菲特概念股,只要250美元就能追随“股神”
为什么沃伦·巴菲特的伯克希尔·哈撒韦现金储备持续膨胀?
华尔街洞察 · 2024-11-05
为什么沃伦·巴菲特的伯克希尔·哈撒韦现金储备持续膨胀?
德维特2024财年第三财季实现净利润2.15亿美元,同比减少12.96%
市场透视 · 2024-11-02
德维特2024财年第三财季实现净利润2.15亿美元,同比减少12.96%
异动解读 | 达维塔保健高昂医疗成本引发业绩下滑 股价暴跌12%
异动解读 · 2024-10-30
异动解读 | 达维塔保健高昂医疗成本引发业绩下滑 股价暴跌12%
异动解读 | 达维塔保健(DVA)业绩不佳导致股价盘中暴跌6.66%
异动解读 · 2024-10-30
异动解读 | 达维塔保健(DVA)业绩不佳导致股价盘中暴跌6.66%
德维特盘中异动 早盘股价大跌8.56%
市场透视 · 2024-10-30
德维特盘中异动 早盘股价大跌8.56%
异动解读 | 达维塔保健高昂的护理成本引发股价暴跌
异动解读 · 2024-10-30
异动解读 | 达维塔保健高昂的护理成本引发股价暴跌
异动解读 | 达维塔保健股价暴跌 病人护理成本上涨引发业绩下滑担忧
异动解读 · 2024-10-30
异动解读 | 达维塔保健股价暴跌 病人护理成本上涨引发业绩下滑担忧
异动解读 | 达维塔保健业绩令人失望 股价盘后大跌6%
异动解读 · 2024-10-30
异动解读 | 达维塔保健业绩令人失望 股价盘后大跌6%
异动解读 | 达维塔保健第三季度利润低于预期,成本增加拖累业绩 股价盘后大跌
异动解读 · 2024-10-29
异动解读 | 达维塔保健第三季度利润低于预期,成本增加拖累业绩 股价盘后大跌
加载更多
公司概况
公司名称:
达维塔保健
所属市场:
NYSE
上市日期:
1995-10-30
主营业务:
DaVita Inc.于1994年在特拉华州注册成立。DaVita是一家领先的医疗保健提供商,致力于改变医疗服务方式,改善全球患者的生活质量。该公司在患者肾脏健康历程的每个阶段和环境中都为他们提供护理—从早期诊断和预防到支持移植过程。
发行价格:
15.50
{"stockData":{"symbol":"DVA","market":"US","secType":"STK","nameCN":"达维塔保健","latestPrice":143.76,"timestamp":1746820800000,"preClose":143.63,"halted":0,"volume":664542,"hourTrading":{"tag":"盘后","latestPrice":143.76,"preClose":143.76,"latestTime":"19:43 EDT","volume":28354,"amount":4076106.61,"timestamp":1746834227439},"delay":0,"floatShares":37831193,"shares":76863300,"eps":10.73,"marketStatus":"休市中","change":0.13,"latestTime":"05-09 16:00:00 EDT","open":143.59,"high":144.415,"low":142.76,"amount":95418854.51238,"amplitude":0.011523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":10.73,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":815029200000,"exchange":"NYSE","adjPreClose":143.63,"preHourTrading":{"tag":"盘前","latestPrice":145,"preClose":143.63,"latestTime":"09:12 EDT","volume":20,"amount":2903.2799999999997,"timestamp":1746796366393},"postHourTrading":{"tag":"盘后","latestPrice":143.76,"preClose":143.76,"latestTime":"19:43 EDT","volume":28354,"amount":4076106.61,"timestamp":1746834227439},"volumeRatio":1.083256393858168,"impliedVol":0.5219,"impliedVolPercentile":0.916},"requestUrl":"/m/hq/s/DVA","defaultTab":"news","newsList":[{"id":"2513084252","title":"巴菲特,又有大动作!","url":"https://stock-news.laohu8.com/highlight/detail?id=2513084252","media":"央视财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513084252?lang=zh_cn&edition=full","pubTime":"2025-02-21 17:13","pubTimestamp":1740129180,"startTime":"0","endTime":"0","summary":"转自:央视财经据路透社报道,近期美国证券交易委员会披露的一份文件显示,美国知名投资人巴菲特旗下伯克希尔-哈撒韦公司在2月14日至19日合计减持美国医疗保健公司达维塔(DaVita)共计75万股,套现约1.15亿美元,约合人民币8.3亿元。此次减持以后,伯克希尔持有达维塔的股份数量降至3514万股,持股比例降至43.93%。据悉,这并非巴菲特第一次减持该股,此前在2月11日也减持了约20万股。从股价表现来看,达维塔近期走势震荡,1月末一度涨至179.60美元/股,但2月14日该股突然暴跌超11%。目前达维塔最新市值为116.7亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221173826abd75f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221173826abd75f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0251142724.SGD","BK4550","IE00B1BXHZ80.USD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU0742534661.SGD","IE000M9KFDE8.USD","LU0157215616.USD","LU0130102774.USD","BK4559","BK4534","BK4581","BK4585","IE0034235303.USD","LU1914381329.SGD","LU0234572021.USD","LU0683600562.USD","IE00B3S45H60.SGD","IE00BK4W5L77.USD","BK4588","BK4196","LU0234570918.USD","LU1074936037.SGD","LU0149725797.USD","IE00B1XK9C88.USD","LU1201861249.SGD","LU0980610538.SGD","IE00B775SV38.USD","LU1366333091.USD","LU1280957306.USD","LU1571399168.USD","BRK.A","BK4176","BRK.B","LU0648001328.SGD","DVA","LU1363072403.SGD","LU0417517546.SGD","LU0256863811.USD","LU0154236417.USD","LU0251131958.USD","IE00BKDWB100.SGD","LU0170899867.USD","LU0053666078.USD","LU0048573561.USD","LU0640476718.USD","LU0971096721.USD","IE00BWXC8680.SGD","BK4533"],"gpt_icon":0},{"id":"2513407001","title":"巴菲特大动作!","url":"https://stock-news.laohu8.com/highlight/detail?id=2513407001","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513407001?lang=zh_cn&edition=full","pubTime":"2025-02-21 08:22","pubTimestamp":1740097364,"startTime":"0","endTime":"0","summary":"伯克希尔哈撒韦减持达维塔,套现1.16亿美元中国基金 报记者吴君“股神”巴菲特又出手了。这并非巴菲特第一次减持该股,此前在2月11日也减持了约20万股。此次减持以后,伯克希尔持有达维塔的股份数量降至3514.25万股,持股比例降至43.93%。事实上,这并非巴菲特今年首次抛售该股。近期披露的13F文件显示,截至2024年四季度末,伯克希尔持有达维塔共计3609.56万股,期末持股市值为53.98亿美元,占其组合总市值的2.02%,达维塔位列伯克希尔第十大重仓股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221083208a24dcbf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221083208a24dcbf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0130102774.USD","LU0154236417.USD","IE00BKDWB100.SGD","LU0234572021.USD","LU0170899867.USD","LU1571399168.USD","BK4581","IE0034235303.USD","LU0234570918.USD","IE000M9KFDE8.USD","IE00BWXC8680.SGD","BRK.B","LU0787776722.HKD","BRK.A","IE00BK4W5L77.USD","LU0251142724.SGD","LU0048573561.USD","LU0648001328.SGD","LU0971096721.USD","IE00B3S45H60.SGD","LU0683600562.USD","LU0251131958.USD","BK4550","LU0742534661.SGD","DVA","IE00BK4W5M84.HKD","LU0157215616.USD","BK4585","LU0053666078.USD","LU1074936037.SGD","LU1201861249.SGD","BK4196","LU1914381329.SGD","LU0980610538.SGD","BK4534","LU0256863811.USD","LU1366333091.USD","BK4559","IE00B1XK9C88.USD","IE00B775SV38.USD","LU1363072403.SGD","BK4176","BK4533","LU0640476718.USD","LU0149725797.USD","BK4588","LU1280957306.USD","IE00B1BXHZ80.USD","LU0417517546.SGD"],"gpt_icon":1},{"id":"2512267829","title":"德维特2024财年实现净利润9.36亿美元,同比增加35.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512267829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512267829?lang=zh_cn&edition=full","pubTime":"2025-02-18 00:00","pubTimestamp":1739808034,"startTime":"0","endTime":"0","summary":"2月18日,德维特公布财报,公告显示公司2024财年净利润为9.36亿美元,同比增加35.26%;其中营业收入为128.16亿美元,同比增加5.57%,每股基本收益为11.02美元。从资产负债表来看,德维特总负债158.81亿美元,其中短期债务6.81亿美元,资产负债比为1.14,流动比率为1.27。机构评级:截至2025年2月18日,当前有7家机构对德维特目标价做出预测,其中目标均价为167.00美元,其中最低目标价为145.00美元,最高目标价为186.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218000043a2496358&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218000043a2496358&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DVA"],"gpt_icon":0},{"id":"2511699051","title":"德维特盘中异动 急速跳水12.48%报154.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511699051?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543565,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分,德维特股票出现波动,股价大幅下挫12.48%。截至发稿,该股报154.97美元/股,成交量13.4784万股,换手率0.17%,振幅1.69%。最近的财报数据显示,该股实现营业收入32.64亿美元,净利润2.15亿美元,每股收益2.56美元,毛利9.25亿美元,市盈率14.44倍。德维特股票所在的医疗设施行业中,整体跌幅为0.35%。该公司在全球拥有 3,000 多家设施,大部分位于美国,每年在全球治疗约 250,000 名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223245a246012c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223245a246012c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4559","BK4196","BK4588","DVA","BK4585"],"gpt_icon":0},{"id":"2511574695","title":"业绩指引疲软、大股东巴菲特抛售 DaVita(DVA.US)盘前走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2511574695","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511574695?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:15","pubTimestamp":1739542500,"startTime":"0","endTime":"0","summary":"智通财经APP注意到,DaVita 周五在盘前继续走低,因大股东伯克希尔哈撒韦公司的内部出售加剧了该公司在 2024 年第四季度业绩中发布的 2025 年展望所导致的抛售。截至发稿,DaVita 盘前跌9.3%,报160.59美元。DaVita在周四盘后交易中大幅下跌,此前该公司将 2025 年调整后收益预期设定为每股 10.20 美元至 11.30 美元,低于普遍预期的每股 11.44 美元。财报还显示,DaVita四季度营收32.947亿美元,预期值为32.66亿美元;每股收益为2.24美元,预期值为2.14美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0130102774.USD","LU0154236417.USD","IE00BKDWB100.SGD","LU0234572021.USD","LU0170899867.USD","LU1571399168.USD","BK4581","IE0034235303.USD","LU0234570918.USD","IE000M9KFDE8.USD","IE00BWXC8680.SGD","BRK.B","LU0787776722.HKD","BRK.A","IE00BK4W5L77.USD","LU0251142724.SGD","LU0048573561.USD","LU0648001328.SGD","LU0971096721.USD","IE00B3S45H60.SGD","LU0683600562.USD","LU0251131958.USD","BK4550","LU0742534661.SGD","DVA","IE00BK4W5M84.HKD","LU0157215616.USD","BK4585","LU0053666078.USD","LU1074936037.SGD","LU1201861249.SGD","BK4196","LU1914381329.SGD","LU0980610538.SGD","BK4534","LU0256863811.USD","LU1366333091.USD","BK4559","IE00B1XK9C88.USD","IE00B775SV38.USD","LU1363072403.SGD","BK4176","BK4533","LU0640476718.USD","LU0149725797.USD","BK4588","LU1280957306.USD","IE00B1BXHZ80.USD","LU0417517546.SGD"],"gpt_icon":1},{"id":"1169201122","title":"异动解读 | 达维塔保健2025年利润预期低于预期,股价盘后暴跌近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169201122","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169201122?lang=zh_cn&edition=full","pubTime":"2025-02-14 07:08","pubTimestamp":1739488114,"startTime":"0","endTime":"0","summary":"达维塔保健(DVA)盘后大跌9.75%,引起投资者广泛关注。分析人士指出,公司2025年利润预期低于市场预期,成为股价下跌的主要推手。\n\n该公司周四公布,预计2025年每股利润在10.2至11.3美元之间,中间值低于分析师的平均预期11.24美元。在盘后交易中,公司股价随即暴跌11%。\n\n导致利润预期不佳的主要原因是患者治疗成本持续上升,包括人工、医疗福利等成本增加,同时也受到自然灾害等其他因素影响。与此同时,关闭一些透析中心还给公司带来额外费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | 达维塔保健2025年利润预期低于预期,股价盘后暴跌近10%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"2511570263","title":"DaVita(DVA.US):2024年Q4财报实现营收32.947亿美元,前值为31.46亿美元,预期值为32.66亿美元;每股收益为2.24美元,前值为1.87美元,预期值为2.14美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511570263","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511570263?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:24","pubTimestamp":1739481893,"startTime":"0","endTime":"0","summary":"DaVita(DVA.US):2024年Q4财报实现营收32.947亿美元,前值为31.46亿美元,预期值为32.66亿美元;每股收益为2.24美元,前值为1.87美元,预期值为2.14美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14052448151081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["DVA"],"gpt_icon":0},{"id":"1118800451","title":"DaVita第四季度调整后每股收益$2.24,超过预期的$2.14,销售额$32.9亿超过预期的$32.7亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1118800451","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118800451?lang=zh_cn&edition=full","pubTime":"2025-02-14 05:09","pubTimestamp":1739480961,"startTime":"0","endTime":"0","summary":"DaVita 报告季度每股收益为$2.24,高于分析师预期的$2.14,超出4.67%。这比去年同期的销售额$31.5亿增长了4.73%。以上内容来自Benzinga Earnings专栏,原文如下:DaVita reported quarterly earnings of $2.24 per share which beat the analyst consensus estimate of $2.14 by 4.67 percent. This is a 19.79 percent increase over earnings of $1.87 per share from the same period last year. The company reported quarterly sales of $3.29 billion which beat the analyst consensus estimate of $3.27 billion by 0.86 percent. This is a 4.73 percent increase over sales of ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"DaVita第四季度调整后每股收益$2.24,超过预期的$2.14,销售额$32.9亿超过预期的$32.7亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"gpt_icon":0},{"id":"1167500379","title":"三只值得散户入手的巴菲特概念股,只要250美元就能追随“股神”","url":"https://stock-news.laohu8.com/highlight/detail?id=1167500379","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167500379?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:00","pubTimestamp":1734940825,"startTime":"0","endTime":"0","summary":"投资者会获得丰厚的回报。","market":"us","thumbnail":"https://static.tigerbbs.com/f3ecc14db02762fcb82cdbb76e654301","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f3ecc14db02762fcb82cdbb76e654301"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KHC","DVA","KO"],"gpt_icon":0},{"id":"1182484165","title":"为什么沃伦·巴菲特的伯克希尔·哈撒韦现金储备持续膨胀?","url":"https://stock-news.laohu8.com/highlight/detail?id=1182484165","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182484165?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:35","pubTimestamp":1730770501,"startTime":"0","endTime":"0","summary":"展望未来,伯克希尔·哈撒韦最近刚刚加入了市值达万亿美元的俱乐部,并在这个周末冻结了股票回购,这可能进一步增加其巨额现金储备。需要注意的是,在当前利率环境下,这笔现金储备为伯克希尔带来了35亿美元的收益,这与其现金和国债头寸相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KO","AXP.AU","BRK.A","LU0053666078.USD","CB","LU0052756011.USD","BAC","SIRI","LU1988902786.USD","KHC","IE00BVYPNW00.USD","C","OXY","CVX","AAPL","IE00BJTD4V19.USD","MCO","BRK.B","AXP","DVA"],"gpt_icon":1},{"id":"2480758518","title":"德维特2024财年第三财季实现净利润2.15亿美元,同比减少12.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480758518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480758518?lang=zh_cn&edition=full","pubTime":"2024-11-03 00:01","pubTimestamp":1730563278,"startTime":"0","endTime":"0","summary":"11月3日,德维特公布财报,公告显示公司2024财年第三财季净利润为2.15亿美元,同比减少12.96%;其中营业收入为32.64亿美元,同比增加4.58%,每股基本收益为2.56美元。从资产负债表来看,德维特总负债152.84亿美元,其中短期债务7.01亿美元,资产负债比为1.15,流动比率为1.38。机构评级:截至2024年11月3日,当前有7家机构对德维特目标价做出预测,其中目标均价为163.71美元,其中最低目标价为145.00美元,最高目标价为186.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DVA"],"gpt_icon":0},{"id":"1118458400","title":"异动解读 | 达维塔保健高昂医疗成本引发业绩下滑 股价暴跌12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118458400","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118458400?lang=zh_cn&edition=full","pubTime":"2024-10-31 05:20","pubTimestamp":1730323259,"startTime":"0","endTime":"0","summary":"透析服务商达维塔保健股价在10月30日盘中出现12.67%的暴跌,引发市场广泛关注。这一暴跌主要归咎于公司第三季度业绩不佳、利润大幅下滑。达维塔保健当日公布的最新财报显示,第三季度公司营收32.6亿美元,符合预期。数据显示,该季度达维塔保健每次治疗病人的护理成本达到257.46美元,同比有所上涨。但本季度这一成本的失控导致公司利润率水平大幅下滑,引发投资者对其未来业绩前景的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1194614074","title":"异动解读 | 达维塔保健(DVA)业绩不佳导致股价盘中暴跌6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194614074","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194614074?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:37","pubTimestamp":1730295430,"startTime":"0","endTime":"0","summary":"达维塔保健在2024年10月30日盘中出现6.66%的暴跌,引起了市场的广泛关注。暴跌主要原因在于公司于前一日晚间公布了第三季度财报,营收略低于预期且利润严重下滑。造成利润大幅下滑的主要原因是公司的薪酬、医疗福利和其他患者护理相关费用在本季度显著增加,导致患者护理成本大幅上升。数据显示,达维塔保健第三季度每次治疗病人的护理成本为257.46美元,同比上涨。投资者对公司业绩前景的看空预期最终导致股价在30日盘中暴跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"2479264783","title":"德维特盘中异动 早盘股价大跌8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479264783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479264783?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295133,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分,德维特股票出现波动,股价大幅下挫8.56%。截至发稿,该股报144.76美元/股,成交量4.5854万股,换手率0.06%,振幅2.82%。德维特股票所在的医疗设施行业中,整体跌幅为0.48%。德维特公司简介:达维塔保健是美国最大的透析服务提供商,按患者和诊所计算,其市场份额超过 35%。该公司在全球拥有 3,000 多家设施,大部分位于美国,每年在全球治疗约 250,000 名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021321495bd8e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021321495bd8e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4559","DVA","BK4196"],"gpt_icon":0},{"id":"1133272896","title":"异动解读 | 达维塔保健高昂的护理成本引发股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1133272896","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133272896?lang=zh_cn&edition=full","pubTime":"2024-10-30 20:30","pubTimestamp":1730291449,"startTime":"0","endTime":"0","summary":"达维塔保健在10月30日美股夜盘交易中出现6.2%的大跌,引发了市场的广泛关注。这一暴跌的主要原因在于该公司第三季度财报中显示,高昂的患者护理成本正在严重侵蚀公司的利润水平。作为一家领先的透析服务提供商,病人护理成本是达维塔保健最主要的运营支出。具体来看,达维塔保健第三季度营收32.6亿美元,符合分析师预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1175994484","title":"异动解读 | 达维塔保健股价暴跌 病人护理成本上涨引发业绩下滑担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1175994484","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175994484?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:54","pubTimestamp":1730267688,"startTime":"0","endTime":"0","summary":"达维塔保健在10月30日美股夜盘交易中出现5.94%的大跌,引发了市场的广泛关注。根据公司第三季度财报,这一下跌或许与业绩和成本问题有关。据了解,透析企业的主要成本支出在于患者护理开支。达维塔保健的财报数据显示,每次治疗的病人护理成本从第二季度的255.25美元上涨到257.46美元。上涨的护理成本使公司利润受到严重压缩,利润率水平下滑。预计护理成本居高不下的问题在第四季度仍将持续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1189201121","title":"异动解读 | 达维塔保健业绩令人失望 股价盘后大跌6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189201121","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189201121?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:06","pubTimestamp":1730257602,"startTime":"0","endTime":"0","summary":"达维塔保健(DVA)今日盘后股价大跌6.01%,引发了市场的广泛关注。公司此前公布的第三季度财报显示,由于病人护理成本持续上升,第三季度利润不及华尔街预期。\n\n根据统计数据,达维塔保健第三季度调整后每股利润为2.59美元,低于分析师预期的2.73美元。这主要归因于薪酬、医疗福利等患者护理相关支出的大幅增长,已经严重拖累了公司的利润水平。\n\n另一方面,达维塔保健本季度关闭了部分美国透析中心,产生了约1800多万美元的关闭费用,并增加了350万美元的患者护理成本。此外,公司还预计由于供应链断裂导致的透析产品短缺问题将影响其第四季度的业绩表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1101224527","title":"异动解读 | 达维塔保健第三季度利润低于预期,成本增加拖累业绩 股价盘后大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1101224527","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101224527?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:53","pubTimestamp":1730235214,"startTime":"0","endTime":"0","summary":"达维塔保健(DVA)今日盘后股价大跌6.01%,引发了市场的广泛关注。\n公司此前公布的第三季度财报显示,由于病人护理成本持续高企,第三季度利润不及华尔街预期。根据LSEG统计,达维塔保健第三季度调整后每股利润为2.59美元,低于分析师预期的2.73美元。\n虽然公司重申了全年利润预期为每股9.25美元至10.05美元,但投资者显然对公司业绩面临的成本压力感到担忧。作为透析诊所运营商,病人护理开支是达维塔保健最主要的成本支出。如果护理成本持续居高不下,将严重影响公司的利润率水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.davita.com","stockEarnings":[{"period":"1week","weight":0.0186},{"period":"1month","weight":-0.0595},{"period":"3month","weight":-0.1718},{"period":"6month","weight":-0.0394},{"period":"1year","weight":0.0422},{"period":"ytd","weight":-0.0387}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":0.0287},{"period":"3month","weight":-0.0606},{"period":"6month","weight":-0.0566},{"period":"1year","weight":0.0849},{"period":"ytd","weight":-0.0371}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DaVita Inc.于1994年在特拉华州注册成立。DaVita是一家领先的医疗保健提供商,致力于改变医疗服务方式,改善全球患者的生活质量。该公司在患者肾脏健康历程的每个阶段和环境中都为他们提供护理—从早期诊断和预防到支持移植过程。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.004213},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.022462},{"month":3,"riseRate":0.566667,"avgChangeRate":0.020909},{"month":4,"riseRate":0.633333,"avgChangeRate":0.026145},{"month":5,"riseRate":0.633333,"avgChangeRate":0.020793},{"month":6,"riseRate":0.586207,"avgChangeRate":0.045331},{"month":7,"riseRate":0.551724,"avgChangeRate":-0.00759},{"month":8,"riseRate":0.448276,"avgChangeRate":-0.005446},{"month":9,"riseRate":0.586207,"avgChangeRate":0.018916},{"month":10,"riseRate":0.517241,"avgChangeRate":0.0052},{"month":11,"riseRate":0.6,"avgChangeRate":0.052442},{"month":12,"riseRate":0.6,"avgChangeRate":0.043556}],"exchange":"NYSE","name":"达维塔保健","nameEN":"DaVita HealthCare Partners"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达维塔保健,DVA,达维塔保健股票,达维塔保健股票老虎,达维塔保健股票老虎国际,达维塔保健行情,达维塔保健股票行情,达维塔保健股价,达维塔保健股市,达维塔保健股票价格,达维塔保健股票交易,达维塔保健股票购买,达维塔保健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}